Cyclooxygenase-2 expression in lung in patients with congenital heart malformations and pulmonary arterial hypertension

Thoracic and Cardiovascular Surgeon

Volumn 61, Issue 4, 2013, Pages 307-311

  Loukanov, Tsvetomir ^a   Jaschinski, Christoph ^a   Kirilov, Milen ^b   Klimpel, Homa ^a   Karck, Matthias ^a   Gorenflo, Matthias ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

complications; congenital heart disease; pulmonary vascular resistance hypertension; surgery

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; FEMALE; GENE EXPRESSION; HEART SURGERY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LUNG; LUNG BIOPSY; MALE; NEWBORN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; INFANT; LUNG; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84879091325     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0033-1337446     Document Type: Article

References (15)

1. Lindberg L., Olsson A. K., Jögi P., Jonmarker C. How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg: 2002; 123 6 1155 1163
2. Humbert M., Morrell N. W., Archer S. L., et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol: 2004; 43 (12, Suppl S): 13S 24S
3. Bando K., Turrentine M. W., Sharp T. G., et al. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. J Thorac Cardiovasc Surg: 1996; 112 6 1600 1607, discussion 1607-1609
4. Tuder R. M., Cool C. D., Geraci M. W., et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med: 1999; 159 6 1925 1932
5. Christman B. W., McPherson C. D., Newman J. H., et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med: 1992; 327 2 70 75
6. Geraci M. W., Gao B., Shepherd D. C., et al. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest: 1999; 103 11 1509 1515
7. Rubin L. J., Mendoza J., Hood M., et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial. Ann Intern Med: 1990; 112 7 485 491
8. Hoshikawa Y., Voelkel N. F., Gesell T. L., et al. Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. Am J Respir Crit Care Med: 2001; 164 2 314 318
9. Fredenburgh L., Liang O., Macias A., et al. Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells. Circulation: 2008; 117 2114 2122
10. Loukanov T., Geiger R., Agrawal R. Animal models related to congenital heart disease and clinical research in pulmonary hypertension. Cardiology: 2010; 116 1 18 25
11. Delannoy E., Courtois A., Freund-Michel V., Leblais V., Marthan R., Muller B. Hypoxia-induced hyperreactivity of pulmonary arteries: role of cyclooxygenase-2, isoprostanes, and thromboxane receptors. Cardiovasc Res: 2010; 85 3 582 592
12. Carratelli M., Porcaro L., Ruscica M., De Simone E., Bertelli A. A., Corsi M. M. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome. Int J Clin Pharmacol Res: 2001; 21 2 79 84
13. Fike C. D., Slaughter J. C., Kaplowitz M. R., Zhang Y., Aschner J. L. Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol: 2008; 295 5 L881 L888
14. Farrow K. N., Lakshminrusimha S., Reda W. J., et al. Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol: 2008; 295 6 L979 L987
15. Lakshminrusimha S., Wiseman D., Black S. M., et al. The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol: 2007; 293 3 H1491 H1497